Press ReleasePosted by Repositive, March 2021New personalised therapeutics partner joins Repositive Cancer Model network
Cancer Models ForumPosted by Henrietta, February 2021Key Takeaways from 'Patient-Derived Organoids for Drug Development and Patient Stratification' webinar
Cancer Models ForumPosted by Henrietta, January 2021Key Takeaways from ‘Bioengineering strategies for early disease detection’ webinar
Press ReleasePosted by Repositive, January 2021New CRO from China joins Repositive Cancer Model network, increasing model database size by 87%
Cancer Models ForumPosted by Henrietta, January 2021Why we are switching our focus to Cancer Model Scout in 2021
Cancer Models ForumPosted by Henrietta, December 2020ZTX™ ONCOLEADS: Shortening time for oncology drug discovery
Press ReleasePosted by Repositive, December 2020Repositive appoints Catherine McDermott as new Chief Executive Officer to deliver implementation of commercial strategy and company scale-up
Cancer Models ForumPosted by Henrietta, December 2020Case Study: how our new platform features make it possible to do your own CMS
Cancer Models ForumPosted by Repositive, November 2020Repositive further expands global network with leading global CRO/CDMO
